Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells 6,464 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) insider Nicholas Hollmeyer Lynton sold 6,464 shares of the business’s stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $3.67, for a total value of $23,722.88. Following the completion of the transaction, the insider now directly owns 91,771 shares of the company’s stock, valued at approximately $336,799.57. The trade was a 6.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Cardlytics Stock Performance

Shares of CDLX traded down $0.32 during trading hours on Monday, reaching $3.49. 2,033,344 shares of the company traded hands, compared to its average volume of 1,212,448. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The business has a fifty day moving average price of $3.93 and a 200-day moving average price of $4.85. Cardlytics, Inc. has a 12-month low of $2.89 and a 12-month high of $20.52. The stock has a market capitalization of $177.37 million, a P/E ratio of -0.57 and a beta of 1.53.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The business had revenue of $67.06 million for the quarter, compared to the consensus estimate of $57.77 million. During the same quarter in the previous year, the business earned ($0.26) EPS. The company’s quarterly revenue was down 15.1% compared to the same quarter last year. Equities analysts anticipate that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Institutional Trading of Cardlytics

Several large investors have recently made changes to their positions in CDLX. RBF Capital LLC raised its holdings in shares of Cardlytics by 311.9% during the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after purchasing an additional 369,620 shares during the last quarter. GSA Capital Partners LLP lifted its holdings in shares of Cardlytics by 1,273.2% in the 3rd quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock valued at $1,223,000 after buying an additional 354,474 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Cardlytics by 711.9% in the second quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock worth $2,882,000 after buying an additional 307,800 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its holdings in Cardlytics by 56.0% during the third quarter. Jacobs Levy Equity Management Inc. now owns 317,644 shares of the company’s stock worth $1,016,000 after acquiring an additional 113,966 shares during the period. Finally, Geode Capital Management LLC raised its position in Cardlytics by 7.5% during the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock valued at $3,371,000 after acquiring an additional 73,484 shares in the last quarter. 68.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CDLX has been the subject of several analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Thursday, November 7th. Evercore ISI assumed coverage on Cardlytics in a report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective for the company. Finally, Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $6.92.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.